Post-transfusion survival of biotin-labeled allogeneic RBCs in adult horses.

The research article is about a study done to understand the post-transfusion survival rate of biotin-labeled allogeneic red blood cells (RBCs) in adult horses. The researchers found that these RBCs survived longer than previously thought, but not as long as in other animal species.

Objective and Hypothesis

• The researchers aimed to determine the post-transfusion survival of N-hydroxysuccinimide (NHS)-biotin-labeled allogeneic equine RBCs when transfused into adult horses.
• The study stemmed from the hypothesis that the survival of these RBCs would be greater than the survival previously reported from studies that used radioactive RBC-labeling techniques.

Methodology

• The study involved adult horses consisting of 5 donors and 5 recipients.
• Each horse was blood-typed and donors were matched with recipients based on blood type and crossmatch results.
• Donor blood of around 4 liters was collected, stored for 24 hours, labeled with NHS-biotin, and re-infused into the recipients.
• Blood samples were collected from the recipients at specified time intervals post-transfusion and were analyzed using flow cytometry.
• The researchers then determined the survival rate at 24 hours, lifespan, and half-life of the biotinylated RBCs.

Results

• The researchers found that on average, 95 ± 24% of the biotinylated RBCs survived 24 hours post-transfusion.
• The mean lifespan of the transfused allogeneic RBCs was 39 days based on a linear regression survival curve.
• The mean post-transfusion RBC half-life observed was 20 days.

Conclusions

• Results showed that the post-transfusion survival of 24-hour stored equine allogeneic RBCs was greater than previously reported.
• However, the survival rate was less than that observed for other companion animal species.
• The researchers stated that the reasons for the relatively short post-transfusion lifespan of allogeneic equine red blood cells remain unknown and thus warrant further research.